Current issues in pediatric medication adherence

被引:0
作者
Matsui D. [1 ,2 ]
机构
[1] Department of Paediatrics, Children's Hospital of Western Ontario, London, Ont.
[2] Children's Hospital of Western Ontario, London, Ont. N6C 2V5
关键词
Children; Patient compliance;
D O I
10.2165/00148581-200709050-00001
中图分类号
学科分类号
摘要
With the recent emphasis on investigating the efficacy of medication in children, it is also important to assess what determines whether pediatric patients do or do not take their medication. In general, children are no better at adhering to drug therapy than older individuals. Dealing with medication nonadherence is essential given its association with a failure to achieve the desired treatment goal. In addition to the many factors that influence adherence in adults, there are some unique challenges faced in the pediatric age group including the role of family (and its dysfunction), the changes of adolescence, and the lack of appropriate drug formulations. Intervention strategies to improve adherence include behavioral and educational strategies. Although there is no consensus as to what is the best approach to promote adherence with therapy, attention should be given to determining what barriers exist and trying to overcome them by involving children and their parents in the treatment planning process. If possible, the medication regimen, taking into account the frequency and timing of administration, should be tailored to the child and family's lifestyle and daily routine. Consideration should be given to the palatability and formulations of medications prescribed for young children. The use of simplified regimens of better tasting medications and age-appropriate delivery mechanisms may enhance the ability of pediatric patients to adhere to their drug therapy. © 2007 Adis Data Information BV. All rights reserved.
引用
收藏
页码:283 / 288
页数:5
相关论文
共 73 条
[1]  
Tebbi C.K., Treatment compliance in childhood and adolescence, Cancer, 71, pp. 3441-3449, (1993)
[2]  
Bonaccorso S., What information do patients need about medicines? Perspectives from the pharmaceutical industry, BMJ, 327, pp. 863-864, (2003)
[3]  
Winnick S., Lucas D.O., Hartman A.L., Et al., How do you improve compliance?, Pediatrics, 115, (2005)
[4]  
Burkhart P.V., Dunbar-Jacob J., Adherence research in the pediatric and adolescent populations: A decade in review, Chronic illness in children: An evidence-based approach, pp. 199-229, (2002)
[5]  
Tilson H.H., Adherence or compliance? Changes in terminology, Ann Pharmacother, 38, pp. 161-162, (2004)
[6]  
Adherence to long-term therapies: Evidence for action, (2006)
[7]  
Urquhart J., How much compliance is enough?, Pharm Res, 13, pp. 10-11, (1996)
[8]  
Ellis S., Shumaker S., Sieber W., Et al., Adherence to pharmacological interventions: Current trends and future directions, Control Clin Trials, 21, (2000)
[9]  
Rudd P., Ahmed S., Zachary V., Et al., Compliance with medication timing: Implications from a medication trial for drug development and clinical practice, J Clin Res Pharmacoepidemiol, 6, pp. 15-27, (1992)
[10]  
Dusing R., Lottermoser K., Mengden T., Compliance with drug therapy: New answers to an old question, Nephrol Dial Transplant, 16, pp. 1317-1321, (2001)